FDA Drug Application (202897) for ACITRETIN by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202897
Product Number001
FormCAPSULE;ORAL
Dosage17.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameACITRETIN
Active IngredientACITRETIN

Active IngredientCount
List of drugs with Active Ingredient ACITRETIN2


Back to FDA Applications sponsored by TEVA PHARMS USA